Article Sidebar
Published:
Sep 5, 2016Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Chemical and biological studies of Lobelia flaccida (C. Presl) A.DC leaf: a medicinal plant used by traditional healers in Eastern Cape, South Africa
Abstract
Purpose: To investigate the phytochemical constituents, acute toxicity and biological activities of Lobelia herb (dried leaf of Lobelia flaccida; family: Campanulaceae), a popular medicinal agent used to manage pain and epilepsy among other indications in Eastern Cape Region of South Africa.
Methods: Essential oil (EO) obtained from the dried leaf was analysed with gas chromatography-mas spectroscopy GC/MS while an infusion extract of the herb was obtained by soaking in hot boiled water (100 oC) for 24 h, filtered and the filtrate dried in vacuo. Phytochemical screening of the infusion extract was performed to detect the presence of secondary plant metabolites and relative abundance of some of the metabolites. The aqueous extract was evaluated for oral (p.o.) acute toxicity (LD50) using the Lorke’s method [30];, thereafter the extract was tested for anti-inflammatory activity on carrageenaninduced rat paw oedema at 250 and 500 mg/kg, p.o., normal saline and aspirin (100 mg/kg, p.o.) used as negative and positive controls respectively. Finally, the extract at 500 and 1000 mg/kg, p.o. was tested for anticonvulsant activity on pentylene tetrazol (85 mg/kg, intraperitoneally)-induced convulsion model in mice, normal saline and diazepam (1 mg/kg, i.p.) served as negative and positive control groups respectively.
Results: EO yield was 0.022 % w/w and the two major compounds identified were acetophenone (26.37 %) and caryophyllene (17.35 %). Phytochemical screening showed high concentration of alkaloids, saponins and flavonoids among other constituents. LD50 of the aqueous extract was ≥ 5000 mg/kg per oral while the aqueous extract exhibited significant (p < 0.01) anti-inflammatory activity on carrageenan-induced rat paw oedema comparable to aspirin but insignificant anticonvulsant activity on pentylene tetrazol-induced convulsion when compared with diazepam.
Conclusion: Lobelia herb is non-toxic, and possesses significant anti-inflammatory and mild anticonvulsant activities. It is suggested that the essential oil of this herb should be screened for pharmacological activities.
Keywords: Lobelia flaccida, Essential oil, Gas chromatography/mass spectroscopy analysis , Infusion extract, Acute toxicity, Anti-inflammatory, Anti-convulsant
